We assessed(1) angiogenic factors in patients with stable angina and longstanding(< 24 months) total occlusion of a single coronary artery and(2) the relation between plasma levels of angiogenic factors and the dev...We assessed(1) angiogenic factors in patients with stable angina and longstanding(< 24 months) total occlusion of a single coronary artery and(2) the relation between plasma levels of angiogenic factors and the development of collateral vessels as evaluated by coronary angiography. Plasma concentrations of vascular endothelial growth factor(VEGF165), fibroblast growth factor, placenta- derived growth factors(PlGFs), and hepatocyte growth factor were assessed in 96 patients with stable angina and longstanding(< 24 months) total occlusion of a single coronary artery. According to coronary angiographic results, 18 patients had no visible collaterals(group 0), 21 patients had visible collaterals but no filling of the recipient epicardial vessel(group 1), and 57 patients showed filling(partial or complete) of the recipient epicardial vessel by collaterals(group 2). Plasma VEGF165 and PlGF concentrations were higher in group 1 than in groups 0 and 2(VEGF165 75 pg/ml, range 24 to 105, vs 23 pg/ml, range 15 to 29, and 19 pg/ml, range 10 to 41, respectively, F=5.53, p=0.006; PlGF 35 pg/ml, range 3.5 to 105, vs 1 pg/ml, range 1 to 38, and 1 pg/ml, range 1 to 5, respectively, F=7.09, p=0.008). Plasma VEGF165 and PlGF levels were similar in groups 0 and 2. There was no significant difference in plasma levels of fibroblast and hepatocyte growth factor concentrations across the 3 groups. In conclusion, plasma levels of angiogenic growth factors differ among patients with stable angina pectoris and longstanding total coronary occlusion.展开更多
文摘We assessed(1) angiogenic factors in patients with stable angina and longstanding(< 24 months) total occlusion of a single coronary artery and(2) the relation between plasma levels of angiogenic factors and the development of collateral vessels as evaluated by coronary angiography. Plasma concentrations of vascular endothelial growth factor(VEGF165), fibroblast growth factor, placenta- derived growth factors(PlGFs), and hepatocyte growth factor were assessed in 96 patients with stable angina and longstanding(< 24 months) total occlusion of a single coronary artery. According to coronary angiographic results, 18 patients had no visible collaterals(group 0), 21 patients had visible collaterals but no filling of the recipient epicardial vessel(group 1), and 57 patients showed filling(partial or complete) of the recipient epicardial vessel by collaterals(group 2). Plasma VEGF165 and PlGF concentrations were higher in group 1 than in groups 0 and 2(VEGF165 75 pg/ml, range 24 to 105, vs 23 pg/ml, range 15 to 29, and 19 pg/ml, range 10 to 41, respectively, F=5.53, p=0.006; PlGF 35 pg/ml, range 3.5 to 105, vs 1 pg/ml, range 1 to 38, and 1 pg/ml, range 1 to 5, respectively, F=7.09, p=0.008). Plasma VEGF165 and PlGF levels were similar in groups 0 and 2. There was no significant difference in plasma levels of fibroblast and hepatocyte growth factor concentrations across the 3 groups. In conclusion, plasma levels of angiogenic growth factors differ among patients with stable angina pectoris and longstanding total coronary occlusion.
